Baker McKenzie has advised KBC Securities on the formation of a joint venture with Van Lanschot Kempen Investment Banking. KBC Securities, part of the KBC Group,...
KBC Securities and Van Lanschot Kempen Investment Banking Form ECM Joint Venture
Minoryx Therapeutics and Neuraxpharm Group’s Development of a New CNS Therapy in Europe
Baker McKenzie advised Minoryx Therapeutics on the deal. Clifford Chance advised the Neuraxpharm Group. Minoryx Therapeutics, a late-stage biotech company focused on the development of treatments...